Probing the inherent stability of siRNA immobilized on nanoparticle constructs

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 27, 2014, Pages 9739-9744

  Barnaby, Stacey N ^a   Lee, Andrew ^a   Mirkin, Chad A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Biological recognition; Nanotechnology; OliGreen; Polyacrylamide gel electrophoresis

Indexed keywords

2' O METHYL RNA NUCLEOTIDE; ANDROGEN RECEPTOR; DOUBLE STRANDED RNA; ENDONUCLEASE; GOLD NANOPARTICLE; NUCLEIC ACID; NUCLEOTIDE; OLIGONUCLEOTIDE; SINGLE STRANDED RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL ENVIRONMENT; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; RNA DEGRADATION; RNA HYBRIDIZATION; RNA STABILITY; RNA SYNTHESIS;

BIOLOGICAL RECOGNITION; NANOTECHNOLOGY; OLIGREEN; POLYACRYLAMIDE GEL ELECTROPHORESIS;

CATALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GOLD; HYDROLYSIS; METAL NANOPARTICLES; OLIGONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING;

EID: 84904016038     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409431111     Document Type: Article

References (32)

1. Love KT, et al. (2010) Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 107(5):1864-1869.
2. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG (2008) LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem 19(11):2156-2162.
3. Tang Y, et al. (2012) Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol Pharm 9(6):1812-1821.
4. Jensen SA, et al. (2013) Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med 5(209):209ra152.
5. Zheng D, et al. (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci USA 109(30):11975-11980.
6. Choi CHJ, Hao L, Narayan SP, Auyeung E, Mirkin CA (2013) Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc Natl Acad Sci USA 110(19):7625-7630.
7. Patel PC, et al. (2010) Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug Chem 21(12):2250-2256.
8. Giljohann DA, et al. (2007) Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett 7(12):3818-3821.
9. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA (2009) Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131(6):2072-2073.
10. Hoerter JA, Walter NG (2007) Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum. RNA 13(11):1887-1893. (Pubitemid 350005215)
11. Behlke MA (2008) Chemical modification of siRNAs for in vivo use. Oligonucleotides 18(4):305-319. (Pubitemid 352791344)
12. Czauderna F, et al. (2003) Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31(11):2705-2716. (Pubitemid 37442115)
13. Shukla S, Sumaria CS, Pradeepkumar PI (2010) Exploring chemical modifications for siRNA therapeutics: A structural and functional outlook. ChemMedChem 5(3):328-349.
14. Peacock H, Kannan A, Beal PA, Burrows CJ (2011) Chemical modification of siRNA bases to probe and enhance RNA interference. J Org Chem 76(18):7295-7300.
15. Lovrinovic M, Niemeyer CM (2005) Rapid synthesis of DNA-cysteine conjugates for expressed protein ligation. Biochem Biophys Res Commun 335(3):943-948. (Pubitemid 41188286)
16. Birmingham A, et al. (2007) A protocol for designing siRNAs with high functionality and specificity. Nat Protoc 2(9):2068-2078. (Pubitemid 351565844)
17. Layzer JM, et al. (2004) In vivo activity of nuclease-resistant siRNAs. RNA 10(5):766-771. (Pubitemid 38529739)
18. Chiu Y-L, Rana TM (2003) siRNA function in RNAi: A chemical modification analysis. RNA 9(9):1034-1048. (Pubitemid 37093614)
19. Harborth J, et al. (2003) Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 13(2):83-105.
20. Volkov AA, et al. (2009) Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect. Oligonucleotides 19(2):191-202.
21. Waltering KK, et al. (2009) Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res 69(20):8141-8149.
22. Zhang J, et al. (2005) Fast separation of single-stranded oligonucleotides by capillary electrophoresis using OliGreen as fluorescence inducing agent. Electrophoresis 26(23):4449-4455. (Pubitemid 41819568)
23. Liu X, Atwater M, Wang J, Huo Q (2007) Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids Surf B Biointerfaces 58(1):3-7. (Pubitemid 46783417)
24. Weickmann JL, Olson EM, Glitz DG (1984) Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer. Cancer Res 44(4):1682-1687. (Pubitemid 14125864)
25. Raines RT (1998) Ribonuclease A. Chem Rev 98(3):1045-1066.
26. Soutschek J, et al. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432(7014):173-178. (Pubitemid 39545841)
27. Hong J, et al. (2010) Comprehensive analysis of sequence-specific stability of siRNA. FASEB J 24(12):4844-4855.
28. Kraynack BA, Baker BF (2006) Small interfering RNAs containing full 2′-O-methyl-ribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity. RNA 12(1):163-176. (Pubitemid 43037463)
29. Choung S, Kim YJ, Kim S, Park HO, Choi YC (2006) Chemical modification of siRNAs to improve serum stabilitywithout loss of efficacy. Biochem Biophys ResCommun 342(3):919-927. (Pubitemid 43320485)
30. Rettig GR, Behlke MA (2012) Progress toward in vivo use of siRNAs-II. Mol Ther 20(3):483-512.
31. MajlessiM, Nelson NC, BeckerMM(1998) Advantages of 2′-O-methyl oligoribonucleotide probes for detecting RNA targets. Nucleic Acids Res 26(9):2224-2229. (Pubitemid 28291770)
32. Shack J (1959) The influence of sodium and magnesium ions on the action of deoxyribonuclease II. J Biol Chem 234(11):3003-3006.